Announcements & Milestones

Partnerships, hires, financings, and platform releases from the Verge Labs team.

2026

• Press · Platform · June 17, 2026
  STAT News: “Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials”
• Platform · CNS · Clinical · June 16, 2026
  Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology
  By Verge Labs
• Partnerships · Pipeline · CNS · June 9, 2026
  Verge Labs and Tenacia Biotechnology Partner to Advance Tenacia’s CNS Pipeline Using Human Data
  By Verge Labs

2025

• Clinical · ALS · Biomarkers · April 7, 2025
  Digital biomarkers detect short-term ALS progression in VRG50635 trial run-in
  By Verge Genomics

2024

• Partnerships · Pipeline · ALS · November 20, 2024
  Lilly selects two ALS targets from CONVERGE® collaboration
  By Verge Genomics

2023

• Clinical · ALS · Pipeline · November 29, 2023
  VRG50635 proof-of-concept study initiated in patients with ALS
  By Verge Genomics
• Partnerships · Neuropsychiatry · October 31, 2023
  Verge Genomics and the Pritzker Consortium form schizophrenia research collaboration
  By Verge Genomics
• Partnerships · Pipeline · Rare Disease · September 8, 2023
  Verge Genomics and Alexion launch AI-enabled drug discovery collaboration for rare neuro diseases
  By Verge Genomics
• Clinical · ALS · Pipeline · June 15, 2023
  Positive Phase 1 safety and tolerability data for VRG50635
  By Verge Genomics

2022

• Leadership · Recognition · November 14, 2022
  Alice Zhang named to Fortune 40 Under 40 and Fierce Biotech’s Fiercest Women in Life Sciences
  By Verge Genomics
• Clinical · ALS · Pipeline · October 31, 2022
  First-in-human dosing of VRG50635 begins in Phase 1 trial
  By Verge Genomics
• Leadership · Recognition · October 12, 2022
  Alice Zhang honored by Goldman Sachs as one of 2022’s Most Exceptional Entrepreneurs
  By Verge Genomics
• Recognition · Company · September 12, 2022
  Fierce Biotech names Verge Genomics a 2022 “Fierce 15” biotech company
  By Verge Genomics

2021

• Partnerships · Pipeline · ALS · July 8, 2021
  Verge Genomics and Eli Lilly announce three-year ALS collaboration
  By Verge Genomics

2020

• Platform · Publication · October 5, 2020
  New approach for uncovering novel drug targets from human genetics published in PLOS Computational Biology
  By Verge Genomics